tiprankstipranks
Trending News
More News >
Clover Biopharmaceuticals Ltd. (HK:2197)
:2197
Hong Kong Market

Clover Biopharmaceuticals Ltd. (2197) Income Statement

Compare
0 Followers

Clover Biopharmaceuticals Ltd. Income Statement

Last quarter (Q4 2024), Clover Biopharmaceuticals Ltd.'s total revenue was ¥48.52M, an increase of Infinity% from the same quarter last year. In Q4, Clover Biopharmaceuticals Ltd.'s net income was ¥-808.30M. See Clover Biopharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 38.42M¥ 39.26M¥ 0.00¥ 0.00¥ 0.00
Gross Profit
¥ -672.94M¥ 24.24M¥ -475.64M¥ -66.27M¥ 0.00
Operating Expenses
¥ 263.50M¥ 24.24M¥ 1.86B¥ 2.16B¥ 284.29M
Depreciation and Amortization
¥ 38.30M¥ 74.74M¥ 60.09M¥ 25.39M¥ 5.78M
EBITDA
¥ -916.54M¥ -45.07M¥ -2.39B¥ -2.23B¥ -335.04M
Operating Income
¥ -951.21M¥ -144.40M¥ -2.45B¥ -6.01B¥ -909.92M
Other Income/Expenses
¥ 47.78M¥ 5.86M¥ -100.70M¥ -3.78B¥ -608.25M
Pretax Income
¥ -903.43M¥ -138.54M¥ -2.45B¥ -6.02B¥ -912.90M
Net Income
¥ -903.43M¥ -138.54M¥ -2.45B¥ -6.02B¥ -915.87M
Per Share Metrics
Basic EPS
¥ -0.72¥ -0.11¥ -2.22¥ -13.02¥ -0.79
Diluted EPS
¥ -0.72¥ -0.11¥ -2.22¥ -13.02¥ -0.79
Weighted Average Shares Outstanding
1.25B 1.24B 1.10B 462.12M 1.16B
Weighted Average Shares Outstanding (Diluted)
1.25B 1.24B 1.10B 462.12M 1.16B
Currency in CNY

Clover Biopharmaceuticals Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis